Bilaketaren emaitzak - Palak Trivedi
- Erakusten 1 - 20 emaitzak -- 45
- Go to Next Page
-
1
Indications, stains and techniques in chromoendoscopy nork Palak Trivedi, Barbara Braden
Argitaratua 2012Revisão -
2
Treatment of autoimmune liver disease: current and future therapeutic options nork Palak Trivedi, Gideon M. Hirschfield
Argitaratua 2013Artigo -
3
-
4
-
5
Obeticholic acid for the treatment of primary biliary cirrhosis nork Palak Trivedi, Gideon M. Hirschfield, M. Eric Gershwin
Argitaratua 2015Revisão -
6
-
7
-
8
Grand round: Autoimmune hepatitis nork Palak Trivedi, Stefan G. Hübscher, Michael Heneghan, Dermot Gleeson, Gideon M. Hirschfield
Argitaratua 2018Revisão -
9
-
10
-
11
-
12
Systematic review with meta‐analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation nork Iris Steenstraten, Kerem Sebib Korkmaz, Palak Trivedi, Akin Inderson, Bart van Hoek, Mar D. M. Rodriguez Girondo, Jeroen Maljaars
Argitaratua 2019Revisão -
13
Loss of CD28 Expression by Liver-Infiltrating T Cells Contributes to Pathogenesis of Primary Sclerosing Cholangitis nork Evaggelia Liaskou, Louisa Jeffery, Palak Trivedi, Gary Reynolds, Shankar Suresh, Tony Bruns, David H. Adams, David M. Sansom, Gideon M. Hirschfield
Argitaratua 2014Artigo -
14
-
15
Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study nork Amera Elzubeir, Juliet High, Matthew Hammond, Lee Shepstone, Martin Pond, Martine Walmsley, Palak Trivedi, Emma Culver, Guruprasad P. Aithal, Jessica Dyson, Douglas Thorburn, Leo Alexandre, Simon Rushbrook
Argitaratua 2025Artigo -
16
The impact of ileal pouch‐anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis nork Palak Trivedi, J. Reece, Richard W. Laing, Emma Slaney, Rachel Cooney, Bridget Gunson, Sivesh K. Kamarajah, Thomas Pinkney, Fiona Thompson, Paolo Muiesan, Andrea Schlegel, Gideon M. Hirschfield, Tariq Iqbal, James Ferguson
Argitaratua 2018Artigo -
17
PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with p... nork Michael Trauner, Chuhan Chung, Kate Sterling, Xiangyu Liu, Xiaomin Lu, Jun Xu, Clare M. Tempany, Zachary Goodman, Martti Färkkilâ, Atsushi Tanaka, Palak Trivedi, Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Robert P. Myers
Argitaratua 2023Artigo -
18
Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a sub... nork Palak Trivedi, Joseph Tickle, Mette Vesterhus, Peter Eddowes, Tony Bruns, Jani Vainio, Richard Parker, David J. Smith, Evaggelia Liaskou, Liv Wenche Thorbjørnsen, Gideon M. Hirschfield, Kaisa Auvinen, Stefan G. Hübscher, Marko Salmi, David H. Adams, Chris J. Weston
Argitaratua 2017Artigo -
19
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis nork Sara Lemoinne, Nora Cazzagon, S. El Mouhadi, Palak Trivedi, Anthony Dohan, Astrid Kemgang, Karima Ben Belkacem, Chantal Housset, Yves Chrétien, Christophe Corpechot, Gideon M. Hirschfield, Annarosa Floreani, Raffaella Motta, B. Gallix, Alan Barkun, Jeffrey Barkun, Olivier Chazouillères, Lionel Arrivé
Argitaratua 2019Artigo -
20
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis nork Peter Fickert, Gideon M. Hirschfield, Gerald Denk, Hanns‐Ulrich Marschall, I Altorjay, Martti Färkkilâ, Christoph Schramm, Ulrich Spengler, R W Chapman, Annika Bergquist, Erik Schrumpf, Frederik Nevens, Palak Trivedi, Florian P. Reiter, István Tornai, Emina Halilbasic, Roland Greinwald, Markus Pröls, Michael P. Manns, Michael Trauner
Argitaratua 2017Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Medicine
Internal medicine
Gastroenterology
Disease
Primary sclerosing cholangitis
Transplantation
Liver transplantation
Ursodeoxycholic acid
Cohort
Primary biliary cirrhosis
Confidence interval
Pathology
Biochemistry
Clinical trial
Hazard ratio
Bilirubin
Biology
Chemistry
Clinical endpoint
Immunology
Proportional hazards model
Surgery
Alkaline phosphatase
Cholestasis
Cirrhosis
Enzyme
Inflammatory bowel disease
Physics
Agonist
Liver disease